A Synthetic Binder of Breast Cancer Stem Cells

被引:2
作者
Chen, Luxi [1 ]
Long, Chao [1 ]
Tran, Kha Andy Minh [1 ]
Lee, Jiyong [1 ]
机构
[1] Univ Texas Dallas, Dept Chem & Biochem, 800 W Campbell Rd, Richardson, TX 75080 USA
关键词
biological chemistry; cancer; high-throughput screening; stem cells; tumors; IDENTIFICATION; PHENOTYPE; SELECTION; FEATURES; SUBTYPES; LIGANDS;
D O I
10.1002/chem.201705663
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cancer stem cells (CSCs) are associated with drug resistance, metastasis and recurrence of cancer. A synthetic binder of CSCs can provide a valuable tool to study the biology of CSCs and a lead to develop imaging, diagnostic and therapeutic agents targeting CSCs. Herein, a synthetic ligand(1) that specifically binds to CSCs over non-CSCs of breast cancer cells was identified for the first time via a cell-binding screening of a chemical library. The ligand 1 showed specific binding to CD24(-)/CD44(+)/ALDH(+) CSC population of MCF-7 and MDA-MB-231. We have demonstrated that 1-immobilized beads can be used as matrices for affinity isolation of 1-binding CSC population from breast cancer cells. The 1-binding population showed significantly increased expressions of stemness-associated transcription factors. Importantly, the 1-binding population demonstrated accelerated tumor growth in vivo, and the resulting tumor displayed an increased migratory activity and high expressions of CSC markers.
引用
收藏
页码:3694 / 3698
页数:5
相关论文
共 28 条
[1]   Novel Small Molecule Inhibitors of Cancer Stem Cell Signaling Pathways [J].
Abetov, Danysh ;
Mustapova, Zhanar ;
Saliev, Timur ;
Bulanin, Denis ;
Batyrbekov, Kanat ;
Gilman, Charles P. .
STEM CELL REVIEWS AND REPORTS, 2015, 11 (06) :909-918
[2]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[3]   Isolation of protein ligands from large peptoid libraries [J].
Alluri, PG ;
Reddy, MM ;
Bachhawat-Sikder, K ;
Olivos, HJ ;
Kodadek, T .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (46) :13995-14004
[4]   Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry [J].
Bauer, Katrina R. ;
Brown, Monica ;
Cress, Rosemary D. ;
Parise, Carol A. ;
Caggiano, Vincent .
CANCER, 2007, 109 (09) :1721-1728
[5]   Residual risk of breast cancer recurrence 5 years after adjuvant therapy [J].
Brewster, Abenaa M. ;
Hortobagyi, Gabriel N. ;
Broglio, Kristine R. ;
Kau, Shu-Wan ;
Santa-Maria, Cesar A. ;
Arun, Banu ;
Buzdar, Arnan U. ;
Booser, Daniel J. ;
Valero, Vincente ;
Bondy, Melissa ;
Esteva, Francisco J. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (16) :1179-1183
[6]   Periodate-triggered cross-linking of DOPA-containing peptide-protein complexes [J].
Burdine, L ;
Gillette, TG ;
Lin, HJ ;
Kodadek, T .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (37) :11442-11443
[7]  
Choi J, 2012, HISTOL HISTOPATHOL, V27, P1481, DOI 10.14670/HH-27.1481
[8]   The cancer stem cell: premises, promises and challenges [J].
Clevers, Hans .
NATURE MEDICINE, 2011, 17 (03) :313-319
[9]   Triple-negative breast cancer: Clinical features and patterns of recurrence [J].
Dent, Rebecca ;
Trudeau, Maureen ;
Pritchard, Kathleen I. ;
Hanna, Wedad M. ;
Kahn, Harriet K. ;
Sawka, Carol A. ;
Lickley, Lavina A. ;
Rawlinson, Ellen ;
Sun, Ping ;
Narod, Steven A. .
CLINICAL CANCER RESEARCH, 2007, 13 (15) :4429-4434
[10]   Stem cell concepts renew cancer research [J].
Dick, John E. .
BLOOD, 2008, 112 (13) :4793-4807